Low-Dose Radiotherapy for Patients with Pneumonia Due to COVID-19: A Single-Institution Prospective Study.

Tomasz Wojciech RutkowskiJerzy JaroszewiczDamian PiotrowskiKrzysztof ŚlosarekBarbara Sobala-SzczygiełDorota SłoninaBożena WłostowskaDawid BoduszMaciej PiaseckiMichał NachlikBarbara Oczko-GrzesikAdam GądekDorota KowalRoman RutkowskiElżbieta Wojarska-TrędaKrzysztof Składowski

Published in: Biomedicines (2023)

LDRT is feasible, well tolerated and may translate to early clinical recovery in patients with severe pneumonia. Further studies are needed to determine optimal candidate, time and dose of LDRT for COVID-19 patients with pneumonia.

Keyphrases

coronavirus disease
sars cov
low dose
early stage
respiratory failure
high dose
respiratory syndrome coronavirus
squamous cell carcinoma
radiation therapy
intensive care unit
early onset
drug induced